Dosimetric correlates for acute esophagitis in patients treated with radiotherapy for lung carcinoma
- PMID: 15001251
- DOI: 10.1016/j.ijrobp.2003.09.080
Dosimetric correlates for acute esophagitis in patients treated with radiotherapy for lung carcinoma
Abstract
Purpose: Acute esophagitis is a common complication of radiotherapy (RT) for non-small-cell carcinoma of the lung. Previous reports have related esophagitis to dosimetric parameters such as the length of the irradiated esophagus, maximal dose, or volume of the organ treated beyond a threshold dose. However, when using oblique beams, a portion of the esophageal circumference may be outside the treated field, resulting in partial esophageal irradiation. Therefore, our aim was to determine whether the irradiated esophageal surface area and/or esophageal volume are predictive of acute esophagitis in relation to other clinical and treatment-related factors.
Methods and materials: Complete dose-volume information was gathered for 166 patients receiving definitive RT for Stage I-IIIB non-small-cell carcinoma of the lung at our institution. Seventy-eight patients received chemotherapy (37 before RT and 41 concurrently). All patients were treated to doses of 60-74 Gy (median, 70 Gy) delivered in single daily fractions of 1.8-2.1 Gy. The doses were prescribed to the isocenter without using heterogeneity corrections; however, the doses were corrected to account for lung heterogeneity in this report. Esophageal contrast was used to contour the esophagus from the cricoid to the gastroesophageal junction in each case. Esophagitis was scored according to the Radiation Therapy Oncology Group criteria with Grade 2 or worse considered clinically significant. To determine the importance of the irradiated surface area, the volumetric treatment plan for each patient was prepared for analysis by relating a surface area to each point of the esophagus contour. Spearman's rank correlation was used to correlate the esophagitis score with A(d), where A represents the surface area (in centimeters squared) receiving the dose, d, or greater (in Gray), or V(d), where V represents the volume (in centimeters cubed) receiving d (in Gray). The surface areas studied were A(5)-A(80) or V(5)-V(80) in 5-Gy increments. The clinical parameters studied in univariate analysis included patient age, stage, performance status, use of pretreatment chemotherapy, and use of concurrent chemotherapy. Step-wise regression analysis was then used to determine the statistically significant factors predicting acute esophagitis.
Results: Forty-five patients (27%) developed Grade 2 or worse esophagitis, 37 developed Grade 2, 7 Grade 3, and 1 Grade 4. No deaths resulted from this complication. The most statistically significant single parameters for predicting acute esophagitis were A(55), V(60), and the use of concurrent chemotherapy. Age, stage, performance status, and pre-RT chemotherapy had no statistically significant influence on the incidence of acute esophagitis. On logistic regression analysis, A(55) (p < or =0.0005), V(60) (p < or =0.001), and the use of concurrent chemotherapy (p = 0.001) emerged as statistically significant correlates of acute esophagitis.
Conclusion: The esophageal surface area receiving > or =55 Gy, the esophageal volume receiving > or =60 Gy, and the use of concurrent chemotherapy were the most statistically significant predictive factors for early esophagitis. Adequate dosimetric coverage of the planning target volume remains the goal of RT planning. High values of A(55) and/or V(60) are indicative of the development of acute esophagitis and may indicate a need to explore alternative RT planning options.
Similar articles
-
Esophagitis, treatment-related toxicity in non-small cell lung cancer.Rev Recent Clin Trials. 2012 Feb;7(1):31-5. doi: 10.2174/157488712799363235. Rev Recent Clin Trials. 2012. PMID: 21864251 Free PMC article. Review.
-
Dosimetric correlations of acute esophagitis in lung cancer patients treated with radiotherapy.Int J Radiat Oncol Biol Phys. 2005 Jul 1;62(3):626-9. doi: 10.1016/j.ijrobp.2005.04.004. Int J Radiat Oncol Biol Phys. 2005. PMID: 15936536
-
Predictors of radiation-induced esophageal toxicity in patients with non-small-cell lung cancer treated with three-dimensional conformal radiotherapy.Int J Radiat Oncol Biol Phys. 2003 Feb 1;55(2):337-41. doi: 10.1016/s0360-3016(02)03937-8. Int J Radiat Oncol Biol Phys. 2003. PMID: 12527046
-
Treatment-related acute esophagitis for patients with locoregionally advanced non-small cell lung cancer treated with involved-field radiotherapy and concurrent chemotherapy.Am J Clin Oncol. 2014 Oct;37(5):433-7. doi: 10.1097/COC.0b013e31827de7a2. Am J Clin Oncol. 2014. PMID: 23388558
-
Dosimetric and clinical predictors for radiation-induced esophageal injury.Int J Radiat Oncol Biol Phys. 2005 Feb 1;61(2):335-47. doi: 10.1016/j.ijrobp.2004.06.014. Int J Radiat Oncol Biol Phys. 2005. PMID: 15667951 Review.
Cited by
-
Mean esophageal radiation dose is predictive of the grade of acute esophagitis in lung cancer patients treated with concurrent radiotherapy and chemotherapy.J Radiat Res. 2012 Nov 1;53(6):916-22. doi: 10.1093/jrr/rrs056. Epub 2012 Aug 21. J Radiat Res. 2012. PMID: 22915782 Free PMC article. Clinical Trial.
-
The efficacy of oral glutamine in prevention of acute radiotherapy-induced esophagitis in patients with lung cancer.Contemp Oncol (Pozn). 2013;17(6):520-4. doi: 10.5114/wo.2013.38912. Epub 2013 Dec 19. Contemp Oncol (Pozn). 2013. PMID: 24592140 Free PMC article.
-
Predicting radiotherapy outcomes using statistical learning techniques.Phys Med Biol. 2009 Sep 21;54(18):S9-S30. doi: 10.1088/0031-9155/54/18/S02. Epub 2009 Aug 18. Phys Med Biol. 2009. PMID: 19687564 Free PMC article.
-
Esophagitis, treatment-related toxicity in non-small cell lung cancer.Rev Recent Clin Trials. 2012 Feb;7(1):31-5. doi: 10.2174/157488712799363235. Rev Recent Clin Trials. 2012. PMID: 21864251 Free PMC article. Review.
-
Dosimetric predictors for acute esophagitis during radiation therapy for lung cancer: Results of a large statewide observational study.Pract Radiat Oncol. 2018 May-Jun;8(3):167-173. doi: 10.1016/j.prro.2017.07.010. Epub 2017 Jul 19. Pract Radiat Oncol. 2018. PMID: 28919249 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical